|
PSMA2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.400900E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.035890E-03 |
| Normal-vs-Stage2 |
5.572200E-02 |
| Normal-vs-Stage3 |
4.191200E-04 |
| Normal-vs-Stage4 |
1.142490E-03 |
| Stage1-vs-Stage2 |
7.354600E-01 |
| Stage1-vs-Stage3 |
4.435400E-01 |
| Stage1-vs-Stage4 |
1.572040E-01 |
| Stage2-vs-Stage3 |
4.352000E-01 |
| Stage2-vs-Stage4 |
2.191200E-01 |
| Stage3-vs-Stage4 |
4.505200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.998900E-04 |
| Normal-vs-AfricanAmerican |
2.443900E-02 |
| Normal-vs-Asian |
1.915160E-03 |
| Caucasian-vs-AfricanAmerican |
9.325800E-01 |
| Caucasian-vs-Asian |
7.141000E-01 |
| AfricanAmerican-vs-Asian |
7.346200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.369840E-04 |
| Normal-vs-Female |
9.172400E-04 |
| Male-vs-Female |
1.691640E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.585000E-03 |
| Normal-vs-Age(41-60Yrs) |
6.218800E-04 |
| Normal-vs-Age(61-80Yrs) |
3.618500E-04 |
| Normal-vs-Age(81-100Yrs) |
1.964150E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.663400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.960220E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.452800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.937600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.138600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.867800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.728400E-01 |
| Classical-VS-Follicular |
1.977410E-01 |
| Classical-VS-Other |
5.597200E-01 |
| Classical-VS-Normal |
2.020700E-03 |
| Tall-VS-Follicular |
3.365800E-01 |
| Tall-VS-Other |
5.628600E-01 |
| Tall-VS-Normal |
2.070400E-02 |
| Follicular-VS-Other |
6.969800E-01 |
| Follicular-VS-Normal |
4.209800E-04 |
| Other-VS-Normal |
2.243400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.011200E-04 |
| Normal-vs-N1 |
2.974800E-04 |
| N0-vs-N1 |
1.048840E-01 |
|
|
